
Sarah McLeod, M.S.
“It is the human experience to try to live in symbiosis with every other organism in order to maintain a peaceful existence. When invasive, parasitic or otherwise destructive organisms invade our bodies, we look backwards, research for etiology, therapies and understanding which then expands our breadth of knowledge to further limitations. It’s the burden of the scientist to remain humble and never stop searching.”
Sarah McLeod, M.S., consults with medical device and biomedical companies to discover the most effective ways of meeting their research data quality objectives. This encompasses a range of interventions from training clinical research staff in data acquisition to monitoring clinicians for protocol adherence to reporting clinically significant outcomes for study report inclusion.
Given the similarities in duties she has held in positions with SIEMENS and Abbott in terms of detailed clinical literature reviews, post-market vigilance database searches, and developing reports that have received notified body approval, Sarah began supporting Nerac January 2023 with its medical writing needs in keeping with EU MDR 2017/745 for medical device regulation and EU IVDR 2017/746 for in vitro diagnostic device (IVDD) regulation.
Areas of Expertise
- Oncology
- HIV/AIDS
- COVID-19
- Class D Infectious Diseases
- EU IVDR 2017/746
Industries
- Pharmaceuticals
- Medical Devices
Credentials
- Doctoral Student, Health Professions and Related Clinical Sciences, University of Bridgeport
- M.S.H.S., Clinical Research Administration, Trident University International
- B.A., Human Services, The George Washington University
- Scientific Writing Certification, Stanford University